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Abstract
Assessment of molecular defects that underlie cognitive deficits observed in mendelian disorders provides a unique
opportunity to identify key regulators of human cognition. Congenital Myotonic Dystrophy 1 (cDM1), a multi-system
disorder is characterized by both cognitive deficits and a spectrum of behavioral abnormalities, which include visuo-spatial
memory deficits, anxiety and apathy. Decreased levels of DMPK (Dystrophia Myotonica-protein kinase), SIX5, a transcription
factor or MBNL1 (Muscleblind-like 1), an RNA splice regulator have been demonstrated to contribute to distinct features of
cDM1. Mouse strains in which either Dmpk, Six5 or Mbnl1 are inactivated were therefore studied to determine the relative
contribution of each gene to these cognitive functions. The open field and elevated plus maze tasks were used to examine
anxiety, sucrose consumption was used to assess motivation, whereas the water maze and context fear conditioning were
used to examine spatial learning and memory. Cognitive and behavioral abnormalities were observed only in Mbnl1
deficient mice, which demonstrate behavior consistent with motivational deficits in the Morris water maze, a complex visuo-
spatial task and in the sucrose consumption test for anhedonia. All three models of cDM1 exhibit normal spatial learning
and memory. These data identify MBNL1 as a potential regulator of emotional state with decreased MBNL1 levels underlying
the motivational deficits observed in cDM1.
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Introduction
Myotonic dystrophy (DM1) is a multi-system disorder charac-
terized by muscle weakness, skeletal myotonia, cardiac conduction
defects, ocular cataracts and cognitive and behavioral abnormal-
ities [1]. DM1 is caused by a CTG repeat expansion found in the
39UTR of the DMPK gene and located immediately 59 of the SIX5
gene on chromosome 19 [2,3,4,5]. Repeat expansion results in
three distinct molecular defects that increase in severity as a
function of repeat tract length: first, as consequence of the
aberrant sequestration of the mutant DMPK RNA within the
nucleus, DMPK levels are decreased in DM1 cells [6,7]. Second,
CTG repeat expansion results in the transcriptional down-
regulation of the linked SIX5 allele leading to diminished levels
of SIX5 [8,9]. Third, expression of expanded CUG repeat
sequences have been shown to dysregulate RNA splicing due to
the inactivation of the alternative splice regulator, MBNL1, by
mechanisms that have yet to be fully understood
[10,11,12,13,14,15]. The pleiotropy of the DM1 phenotypes are
thought to result from a combination of these three effects, with
the expression of CUG repeats playing a prominent role in the
development of major aspects of the disease.
Patients with the myotonic dystrophy type 1 exhibit cognitive
and behavioral abnormalities including mental retardation, visuo-
spatial memory deficits, apathy, anxiety, hypersomnolence,
autism, depression and attention deficit hyperactivity disorders
[16,17,18,19,20]. Patient assessment suggests that apathy cannot
be accounted for by depression or muscle weakness and reflects a
CNS involvement [17]. It is also of interest to note that visuo-
spatial reasoning and memory appears to be specifically
compromised in DM1 patients [16]. The severity of psychiatric
illness in DM1 is roughly proportional both to the CTG tract
length and age of disease onset with cognitive and behavioral
deficits showing the greatest prevalance and severity in the
congenital form of the disorder [21].
To investigate the contribution of these genes to cognitive
symptoms observed in DM1 patients, we studied the effect of
deletion of Six5, Dmpk and Mbnl1 on three separate behavioral
tasks designed to test learning and memory, anxiety and
motivation. These three mouse models of DM1 show various
physical phenotypes pertaining to myotonic dystrophy. Dmpk2/2
mice display muscle weakness and heart disease [22,23], Six52/2
mice display cataracts and heart disease [24,25] and Mbnl12/2
mice display skeletal myotonia, muscle weakness, cataracts and
possibly heart disease [15]. Therefore, we carefully chose tasks that
require varying degrees of muscular strength (i.e. low demands in
fear conditioning, higher demands in the water maze) and
performed control tasks when possible (i.e. visible watermaze to
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control for the hidden water maze) in order to dissociate
muscular/physical impairments from higher level brain functional
deficits. Our results demonstrate that neither Six5 nor DmpK
affect cognitive function but that Mbnl12/2 mice have deficits
consistent with decreased motivation.
Results
Mbnl12/2 mice exhibit contradictory anxiety behaviors
We began by assessing anxiety-related behaviors (thigmotaxis or
wall-hugging) and general activity using the Open Field task. In
this task, mice are placed in an open arena and allowed to explore.
No differences in Open Field thigmotaxis (wall-hugging, Figure 1i),
ambulation (total cm traveled, Figure 1ii) or average velocity (cm/
s, Figure 1iii) were detected in the Six52/2 and Dmpk2/2 mutant
mice compared to their wild-type littermate controls (Figure 1A,
and B, respectively). However, Mbnl12/2 mice showed increased
thigmotaxis, and decreased ambulation and average velocity
(Figure 1C). These results show that Mbnl12/2 mice have
decreased overall activity experience. Increased thigmotaxis
exhibited by the Mbnl12/2 mice could be due to muscle weakness,
increased anxiety or decreased motivation to explore.
Since Mbnl12/2 mice showed increased thigmotaxis, but the
cause of this anxiety-related behavior is unclear, we further tested
these mutants in the elevated plus maze, another anxiety test. Mice
are placed on a 4-arm maze in which two arms are sheltered and
the other two arms are open. This configuration presents a ‘‘safe’’
environment in the sheltered, darker arms and a more
‘‘dangerous’’ environment in the two open, lighted arms. Similar
to the open field task, mice that are anxious will spend more time
in the ‘‘safe’’, closed arms.
TheMbnl12/2 mice generally show normal anxiety levels in this
test. They did not show a preference for the closed arms, spending
the same amount of time in the open and closed arms as well as
the center of the maze (Figure 2A, I, ii and iii, respectively).
Although not statistically significant, the Mbnl12/2 mice spend
slightly more time in the open arms compared to their wild-type
littermates. Similarly, the Mbnl12/2 mice spent less time in the
stretch position which is typically indicative of decreased anxiety
(Figure 2B). Lastly,Mbnl12/2mice show the same relative number
of entries into the closed and open arms, although the total
number of entries are decreased (Figure 2C, i, ii and iii,
respectively). However, Mbnl12/2 mice also made fewer head
dips over the side of the maze, which normally indicates increased
anxiety (Figure 2D).
As with the open field test, the observed behavior may have
contributions from decreased motivational drive to explore,
muscular phenotypes or altered anxiety. Indeed, Mbnl12/2 mice
have decreased locomotion in the elevated plus maze, making
significantly fewer total entries and entries into the closed arms.
Although the Mbnl12/2 mice also entered the open arms fewer
times than their wild-type littermates, this was not statistically
significant, probably due to the low number of entries by both the
wild-type and Mbnl12/2 groups of mice (Figure 2C, iii). Overall,
these results indicate that the musculoskeletal deficits in the
Mbnl12/2 mice lead to poor performance on the elevated plus
maze, and result in conflicting indicators of anxiety, namely fewer
head dips and less time in the stretch position. Given these results,
it is likely that their musculoskeletal phenotype is contributing to
poor performance on the elevated plus maze and thus cannot be
directly interpreted. Taken together with the Open Field
phenotype, these results are inconclusive as to whether or not
the Mbnl12/2 mice experience increased anxiety and but do
indicate that the mutant mice have musculoskeletal deficits.
Mbnl12/2, Dmpk2/2 and Six52/2 mice show normal
hippocampus-dependent learning in contextual fear
conditioning
To investigate hippocampal cognitive function, we tested these
three DM1 models in contextual fear conditioning. This is a
hippocampus-dependent task that measures formation of predic-
tive associations. In context fear conditioning, mice are placed in a
training chamber, allowed to explore and subsequently given a
mild foot shock. In this paradigm, the mouse learns that the
specific context predicts the foot shock and will exhibit fear
responses such as freezing (lack of all movement except for
breathing) when returned to the same context.
Six52/2, Dmpk2/2 and Mbnl12/2 mice show no deficits in
hippocampus-dependent context fear conditioning (Figure 3Ai, Bi
and Ci, respectively). Both freezing (Figure 3A) and activity
suppression (the relative decrease in locomotor activity of post-
training to pre-training levels, Figure 3B) in a test performed 7
Figure 1. Inactivation of Six5 or Dmpk does not affect anxiety or
general motor activity in the Open Field task. Anxiety, as
indicated by thigmotaxis, is shown as % time hugging wall (panels i).
Activity is shown as velocity (cm/s, panels ii) and ambulation (m
traveled, panels iii). A) Six52/2 (white, n = 7) mutant mice display normal
thigmotaxis, velocity and distance travelled compared to their Six5+/+
wild-type littermate controls, (black, n = 6) (panel i, ii, and iii
respectively). B) Dmpk2/2 mutant mice (white, n = 9) display normal
thigmotaxis, velocity and distance travelled compared to their Dmpk+/+
wild-type littermate controls, (black, n = 9) (panel i, ii and iii,
respectively). C) Mbnl12/2 (white, n = 23) mutant mice display increased
thigmotaxis (F(1, 04) = 10.3, p = 0.0026), decreased velocity
(F(1,40) = 14.0, p = 0.0006) and decreased distance travelled
(F(1,40) = 8.10, p = 0.0070) compared to their Mbnl1+/+ wild type
littermate controls (black, n = 19) (panel i, ii and iii, respectively).
doi:10.1371/journal.pone.0009857.g001
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days after training were normal compared to wild-type littermate
controls. Activity suppression normalizes for general activity levels
of the mice and therefore corrects for potential hypo- and hyper-
activity [26].
Although hippocampus-dependent associative conditioning was
normal in all three DM1 disease models, abnormal baseline
activity and activity bursts (the response to the foot shock which
includes jumping and/or running) were observed in Mbnl12/2
mice. Specifically, both Six52/2 and Dmpk2/2 mice displayed
normal baseline activity (pre-traininig locomotor activity,
Figure 3Aiii and Biii, respectively) and foot shock response
(Figure 3Aiv and Biv). In contrast, the Mbnl12/2 mice display
hypo-activity (Figure 3Ciii) and a decreased response to foot shock
(activity burst, Figure 3Diii), consistent with muscle weakness or
myotonia.
All three mutant strains show normal cognitive function
in the Morris water maze, Mbnl12/2 mice exhibit signs of
decreased motivation
To further examine hippocampal function as it relates to visuo-
spatial learning and memory, we performed the Morris water
maze task. In this task, mice are trained daily to find a hidden
platform in a circular pool, using external spatial cues to create a
map of the environment and assist in navigation. The Water Maze
has non-spatial components such as swim velocity, latency or
pathlength during acquisition and thigmotaxis as well as spatial
components, such as spatially-selective search strategies during
probe trials in which the hidden platform is removed [27]. Mice
were given two training trials per day, with probe trials given both
during acquisition and at the end of training.
Figure 2. Inactivation of Mbnl1 does not alter anxiety in the
Elevate Plus Maze. A) Mbnl12/2 (white, n = 14) mutant mice spent
the same amount of time in the open (F(1,26) = 0.76, p = 0.39) and
closed arms (F(1,26) = 0.40, p = 0.53), and the center (F(1,26) = 0.52,
p = 0.48) of the elevated plus maze compared to their Mbnl1+/+ wild
type littermate controls (black, n = 14) (panel i, ii and iii, respectively),
although the Mbnl12/2mice show trends towards decreased anxiety by
spending more time in the open arms. B) Mbnl12/2 mutant mice spent
the significantly less time in a stretch posture, indicative of decreased
anxiety (F(1,26) = 23, p,0.0001) C) Mbnl12/2 (white, n = 14) mutant
mice display decreased overall activity, specifically decreased total
entries into arms (F(1,26) = 8.4, p = 0.0076) which is due to decreased
entries into the closed arms (F(1,26) = 9.4, p = 0.005) and not into open
arms (F(1,26) = 3.6, p = 0.069) and compared to their Mbnl1+/+ wild type
littermate controls (black, n = 14) (panel i, ii and iii, respectively). D)
Mbnl12/2 (white, n = 14) mutant mice display decreased numbers of
head dips (F(1,26) = 5.1, p = 0.032) compared to their Mbnl1+/+ wild type
littermate controls (black, n = 14), incidcative of increased anxiety, in
contrast to B).
doi:10.1371/journal.pone.0009857.g002
Figure 3. Inactivation of Six5, Dmpk or Mbnl1 does not affect
Pavlovian contextual fear conditioning. The percent time freezing
(panels i) and the activity suppression ratios (a ratio of locomotor
activity levels which corrects for hyper- and hypo-activity, panels ii) are
shown for baseline (bl) and 7-day (7 d) memory of context fear
conditioning. Baseline activity levels (arbitrary units) prior to the foot
shock (panels iii) and activity bursts (velocity, cm/s, panels iv) are
shown. A) Six52/2 (white, n = 7) mutant mice display no differences in
context fear conditioning freezing, activity suppression, activity level or
activity burst phenotypes compared to the Six5+/+ wild type littermate
controls (black, n = 6). B) Dmpk2/2 (white, n = 9) mutant mice display no
differences in context fear conditioning freezing, activity suppression,
activity level or activity burst phenotypes compared to the Dmpk+/+
wild-type littermate controls (black, n = 9). C) Mbnl12/2 (white, n = )
mutant mice display no context fear conditioning phenotype compared
to their Mbnl1+/+ wild-type littermate controls (black, panels i and ii).
However, Mbnl12/2 (white) mutant mice show decreased baseline
activity compared to their Mbnl1+/+ wild type controls (black, panel iii)
(F(1,14) = 6.86, p = 0.020). Mbnl12/2 (white, n = 5) mice also display a
deficit in their unconditioned response to foot shock (activity burst)
compared to their wild type controls (black, n = 12, panel iv) (effect of
activity burst x genotype, repeated measures ANOVA F(1,14) = 15,
p = 0.0018).
doi:10.1371/journal.pone.0009857.g003
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Both the Six52/2 (Figure 4A) and Dmpk2/2 (Figure 4B) mutant
strains showed normal acquisition as defined by the latency to find
the platform (Figure 4i), had normal swim speeds (Figure 4ii), and
normal levels of thigmotaxis (Figure 4iii). Mbnl12/2 mice also
improved with time, acquiring the task whether measured as
latency (Figure 4Ci) or pathlength to find the platform (Figure 4Ci
inset). However, we observed several deficits in the Mbnl12/2
mice, including decreased swim speeds and increased levels of
thigmotaxis (Figure 4Cii and iii, respectively). A number of
Mbnl12/2 mice exhibited .10% thigmotaxis by the end of
training so were excluded from these analyses (Figure 4C and D).
If these mice are included, the Mbnl12/2 mice show the same
Figure 4. Mbnl12/2mutant mice have altered acquisition in the Morris Water Maze. A) No differences were found in the latency (seconds)
to find the platform during training (panel i), average velocity (cm/s) during all training days (panel ii) and thigmotaxis (F(1,23) = 2.8, p = 0.11) (% time,
panel iii) for Six52/2mice (white, n = 7) compared to their wild-type littermate controls, Six5+/+ mice (black, n = 6). B) No differences were found in the
latency (seconds) to find the platform during training (panel i), average velocity (cm/s) during all training days (panel ii) and thigmotaxis (% time,
panel iii) for Dmpk2/2 mice (white, n = 9) compared to their wild-type littermate controls, Dmpk+/+ mice (black, n = 9). C) No statistical differences
were found in the latency (seconds) to find the platform during training (panel i) (effect of genotype x latency using 2-day blocks, repeated measures
ANOVA, F(6,210) = 1.19, p = 0.31) for Mbnl12/2 mice (white, n = 13) compared to their wild-type littermate controls, Mbnl1+/+ mice (black, n = 24). C
inset: The pathlength (m) to reach the target platform of Mbnl12/2 (white) was the same as Mbnl1+/+ mice (black) during acquisition (effect of
genotype x latency F(6,210) = 1.92, p = 0.080). In contrast, Mbnl12/2 mutant mice (white) had a slower average velocity during all training days (cm/s,
panel ii) (F(1,35) = 38.5, p =,0.0001) and increased thigmotaxis (% time, panel iii) (F(1,35) = 6.47, p = 0.015) compared to their wild-type littermate
controls, Mbnl1+/+ mice (black). D) The % time spent swimming slowly (floating behavior) of Mbnl12/2 (white) increased compared to Mbnl1+/+ mice
(black) during acquisition (F(1,35) = 15.7, p = 0.0004; effect of genotype x latency F(6,210) = 6.53, p =,0.0001). Mbnl12/2 mice showed increased
floating behavior in all training blocks except blocks 1 and 3. E) Mbnl12/2 mice (white) displayed normal acquisition in the visible water maze task
(pathlength (m), (effect of genotype x pathlength using 2-day blocks, repeated measures ANOVA, F(6,70) = 0.885, p = 0.42)). Training blocks represent
1 day (2 training trials) for both Six52/2 and Dmpk2/2 mutant mice, and two days (4 training trials) for Mbnl12/2 mutant mice. Mbnl12/2 and Mbnl+/+
mice exhibiting .10% thigmotaxis on the last day of training were excluded from these analyses. See Figure S1 for data including all Mbnl1 mice.
doi:10.1371/journal.pone.0009857.g004
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swim speed but even greater thigmotaxis (Figure S1A). These data
are consistent with decreased muscle strength observed in the
Mbnl12/2 mice [15].
Interestingly, as training proceeded, Mbnl12/2 mice spent more
time ‘‘floating’’ (% time floating, Figure 4D). This represents an
inability to switch from a passive strategy to a spatially selective
strategy and is typically indicative of decreased motivation [27].
This phenotype was not observed in either the Six52/2 or Dmpk2/
2 mice (data not shown). This is unlikely to be caused by muscular
fatigue or myotonia for the following reasons. First, the Mbnl12/2
mice perform normally in the visible watermaze (Figure 4E) which
involved three sequential trials compared to two sequential trials in
the hidden platform task, and was performed after the hidden
watermaze. Consequently, if the Mbnl12/2 mice were fatigued,
this should be more evident in the visible watermaze. Second,
myotonia exhibits a ‘‘practice effect’’ meaning that the failure of
muscle relaxation after contraction decreases with even a short
warm-up period of activity [28]. Importantly, this phenotype was
not observed at the beginning of training but only manifested after
probe trials in which the hidden platform is removed. Thus, these
factors are consistent with the hypothesis that the Mbnl12/2 mice
‘‘give up’’ when the task is too difficult, suggesting motivational
deficits instead of muscular fatigue or weakness.
Six52/2, Dmpk2/2 and Mbnl12/2 mutant mice showed normal
spatial learning and memory, searching selectively for the platform
(Figure 5A, B, and C respectively). If, however, spatial learning
and memory is assessed with the inclusion of theMbnl12/2mutant
mice that exhibited high levels of thigmotaxis at the end of
training, they showed a deficit in spatial memory, randomly
searching for the platform in all quadrants (% time in target
quadrant Figure S1D). Importantly, Mbnl12/2 mutant mice had
normal acquisition when trained in the visible water maze task
which is marked by a local cue and has the same physical
requirements but involves different cognitive capacities (Figure 5E
and Figure S1C). Therefore, the visible water maze controls for
performance indicating that the decrease spatial ability in the
Mbnl12/2 mice is not due to decreased vision from cataracts, or
muscular complications such as myotonia, decreased skeletal
muscle strength or cardiac complications.
Mbnl12/2 mice show decreased sucrose consumption in
a test for anhedonia
The performance of the Mbnl12/2 mice in the watermaze
suggested that these mutants may have motivational deficits. To
directly test apathy in these mutants, we chose a task that has
minimal physical requirements. The sucrose consumption test, a
classic anhedonia test, presents the mouse with a two bottle choice,
one bottle contains water and the other contains a solution of
sucrose. During habituation, Mbnl12/2 mice drank the same
amount of water as their wild-type controls (Figure 6A). However,
Mbnl12/2 mice showed no preference for sucrose compared to the
wild-type mice for 2%, 4% and 8% sucrose (Figure 6B). Given a
large enough reward of 16% sucrose, Mbnl12/2 mice showed a
increased consumption of sucrose, drinking a similar volume of
sucrose as their wild-type littermates (Figure 6B). The Mbnl12/2
mice showed a lack of interest in sucrose, a behavior typical of
decreased motivation.
Discussion
Patients with myotonic dystrophy have numerous physical
symptoms, including musclular, skeletal, cardiac and vision
difficulties. It has been long realized that they experience cognitive
impairment, with a lower IQ overall and specific deficits in
attention, visuo-spatial function, perception, executive function
and autism spectrum disorder symptoms [16] [29] [17] [19] [20].
Apathy, hypersomnia and anxiety have been more recently
associated with myotonic dystrophy and are dissociable from the
physical disabilities. They appear to be explicit symptoms of the
disease, and like the physical symptoms, there is a correlation with
the severity of disease and cognitive deficits in which less severely
affected patients generally have milder cognitive deficits.
The pleiotropy of this disease is reflected in symptoms, their
severity and the molecular alterations that occurs. The disease is
caused by a trinucleotide repeat expansion situated in the 39UTR
of the DMPK gene, located immediately 59 of the SIX5 gene but
the core of the biochemical defect is sequestration of MBNL1 by
the expanded trinucleotide repeat RNA in nuclear foci. RNA
processing is disrupted, in part due to inactivation of the
Figure 5. All three mutant mouse strains have normal spatial memory in the Morris Water Maze. The percent time spent in the Target
Quadrant (TQ), Adjacent Left (AL), Adjacent Right (AR) or Opposite Quadrant (OP) is shown. A score of 25% reflects random searching. Probe test
results after training are shown. A) No differences were found in the percent time spent in the searching in each quadrant on day 7 as shown for
Six5+/+ (black, n = 6) and Six52/2 (white, n = 7) mice. B) The percent time spent searching in each quadrant on day 7 is shown for Dmpk+/+ (black, n = 9)
and Dmpk2/2 (white, n = 9) mice. C) No differences were found in the percent time spent in searching in each quadrant on day 13 as shown for
Mbnl1+/+ (black, n = 24) and Mbnl12/2 (white, n = 13) mice (genotype x quadrant, repeated measures ANOVA F(3,105) = 2.20, p = 0.092).
doi:10.1371/journal.pone.0009857.g005
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alternative splice regulator, MBNL1 which normally regulates
splicing of several transcripts including Cncl1, a chloride channel
associated with myotonia [30] [15]. This RNA-dominant disease
consequently has many possible molecular alterations that lead to
individual symptoms. Therefore, it is important to ascertain which
molecular alteration leads to the cognitive and emotional deficits
seen in DM1 patients.
Neither Six52/2 nor Dmpk2/2 mice appear to affect cognitive
function in mouse models of DM1. In DM1, a trinucleotide repeat
is expanded and disrupts normal RNA processing in the nucleus,
and sequestering Mbnl1 protein in specific foci. Since in both
Six52/2 and Dmpk2/2 mice, there is no trinucleotide repeat, these
mutants can be used to differentiate between the direct effect of a
gene and the effect of impairing the function of other proteins with
which they interact. Supporting the hypothesis that RNA
metabolic disruption is key to the development of DM1 symptoms,
we found deficits only in theMbnl12/2 mice. Mbnl12/2 mice have
normal spatial learning and memory but show severe alterations in
motivated behavior. Specifically, Mbnl12/2 mice showed signs of
motivation and apathy in a physically demanding task (Morris
water maze) or a simple task (sucrose consumption).
Due to their physical symptoms, the cognitive and emotional
phenotype of the Mbnl12/2 mice is difficult to assess. However,
Mbnl12/2 mice show unmotivated behavior in the water maze,
failing to switch from passive strategies to a spatially selective
search as exhibited by increased floating in the watermaze task
[27]. Interestingly, this increased floating only manifested after
probe trials were performed. Combining this observation with
normal performance in the visual watermaze suggests a complex
interaction between the difficulty of the task and a substantial
motivational component that underlie their lack of spatial
acquisition, with the possibility that muscular weakness also
contributes to apathy. Thus, Mbnl12/2 mice may become
unmotivated if they fail to learn the platform location expediently.
A number of Mbnl12/2 mice also exhibited such pronounced
thigmotaxis that they were excluded from final analysis. The
remaining Mbnl12/2 mice showed normal spatial learning and
memory when tested without the platform present, however, the
Mbnl12/2 mice that demonstrated pronounced thigmotaxis did
not show any spatial learning and memory. This demonstrates that
Mbnl1 deficit in these mice results in a range of severity of the
observed phenotypes.
To substantiate a phenotype of decreased motivation, we tested
Mbnl12/2 mice for apathy towards sucrose. The mice were tested
in their home cage with the sucrose and water bottles presented in
their normal location. Therefore, physical complications of this
task are minimal as the physical demands are the same as drinking
water in their home cage: these mutants do not experience
dehydration from an inability to reach the water bottle. In this test
for anhedonia, Mbnl12/2 mice show preference for sucrose over
water at a much reduced rate than their wild-type counterparts.
The Mbnl12/2 mice appear to require a higher reward as a 16%
solution was equally appealing to the Mbnl12/2 mice as a 4%
solution was to the wild-type mice. This suggests that the mutant
mice do not have an innate aversion to sucrose but instead that
they have a decreased interest in seeking a sweet reward. This
finding may be particularly relevant as apathy is a striking feature
in myotonic dystrophy patients and has been shown to be
independent of both clinical depression and peripheral muscular
weakness [17].
In addition to lack of motivation, myotonic dystrophy patients
have increased anxiety. We tested all three mutant mouse strains
for alterations in anxiety levels and only Mbnl12/2 mice exhibited
high levels of thigmotaxis, a behavior indicative of anxiety.
Although Dmpk2/2 and Six52/2 showed no overt anxiety
phenotype in the open field, we performed only one test of
anxiety and thus subtle phenotypes may exist that can be detected
using other tests. In a second test of anxiety, the elevated plus
maze, the Mbnl12/2 mice showed conflicting signs of increased
and decreased anxiety. Given these ambiguous results, it is difficult
to determine if these mice are good models of anxiety observed in
myotonic dystrophy patients. Furthermore, it would be difficult to
determine the basis for their altered performance in either the
open field and elevated plus maze tasks. The underlying cause of
altered performance could be decreased motivation to explore,
increased anxiety or musculoskeletal effect, or a combination of all
three factors, all three of which are consistent with the human
disease.
Finally, contextual associative learning was normal in the
Mbnl12/2 mice. Since DM patients do not show remote memory
deficits, we did not test memory at later times. Specifical
alterations in 24-hour memory consolidated and remote memory
were not tested however, based on a normal memory phenotype at
seven days, which is it is indicative of protein-synthesis dependent
memory and the transition to a remote memory [31,32], we
speculate that all three mutant strains will show relatively normal
memory at these times as well. Taken together, these data suggest
a normal spatial learning, with a complex motivational alteration
that may result in part through an interaction of muscular effects
with emotional state in Mbnl12/2 mice.
Important questions to address in the future will be to assess
motivational drive in Mbnl12/2 mice with normal musculoskeletal
function. Since these are separable in patients with DM1, it is
likely that the transcripts controlled by Mbnl1 processing may play
Figure 6. Inactivation of Mbnl1 results in decreased sucrose
consumption, a measure of motivation. A) Mbnl12/2 (white,
n = 14) mutant mice consume the same amount of water during
habituation (0%) as well as during presentation of sucrose (2, 4, 8 and
16%) (genotype x water, repeated measures ANOVA F(4,104) = 1.67,
p = 0.16) main effect of genotype (F(1,26) = 2.64, p = 0.12) compared to
their wild-type littermate controls (black, n = 14). B) In contrast,
Mbnl12/2 mutant mice consume less sucrose, regardless of the percent
sucrose (genotype x sucrose, repeated measures ANOVA F(3,78) = 3.79,
p = 0.014) main effect of genotype (F(1,26) = 6.23, p = 0.018). The
Mbnl12/2 mutant mice drink less 2% (ANOVA F(1,26) = 4.96,
p = 0.035), 4% (ANOVA F(1,26) = 4.46, p = 0.044), and 8% (ANOVA
F(1,26) = 7.71, p = 0.010) sucrose but statistically consume the same
amount of 16% (ANOVA F(1,26) = 3.00, p = 0.095) sucrose as their wild-
type littermates, indicating that the mutant mice can taste and
discriminate between water and the sweet solution.
doi:10.1371/journal.pone.0009857.g006
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a specific role in apathy and motivation. The specific transcripts
that undergo altered splicing due to Mbnl1 are not all known.
Deep sequencing of the different mutant models of DM1 will be
very useful in generating and further refining genotype/phenotype
relationships. Mbnl1 belongs to a three-member family, and the
role of specific Mbnl family members may further refine our
understanding of the transcriptional misregulation that leads to
specific symptoms [33]. The lack of these specific phenotypes in
the Dmpk2/2 and Six52/2 mice suggests that these genes do not
play a role in motivation when they are specifically deleted but
their dysfunction, as caused by the DM1 trinucleotide repeat
expansion, may still participate in generating cognitive effects in
patients. Defining the specific regions of the brain that show
functional impairment in Mbln1 knockout mice and identification
of Mbnl1 target RNAs in these areas will be critical to
understanding this complex phenotype. These lines of inquiry
should allow key insights into the molecular targets and circuits
that regulate motivation, and spatial learning and memory in
humans.
Materials and Methods
Mice
All experiments were performed in accordance with the
institutional guidelines of the University of California at Los
Angeles. For all tasks, male and female mice in the 129B6 genetic
background were generated from heterozygous matings and all
tests used mutant mice with their respective wild type littermates as
controls. All mice were group-housed, maintained in a 12:12 light/
dark cycle and had food and water ad libitum. Six52/2, Dmpk2/2,
and Mbnl12/2 mice have been previously described
[15,22,23,24,25]. All mice were tested between the ages of 8–14
months, Six52/2 mice ranged from 8–12 months, Dmpk2/2 mice
were 8–10 months and Mbnl12/2 mice were 8–14 months at the
time of testing. Mice were used for multiple tests in this order:
open field, watermaze, fear conditioning or open field, elevated
plus maze, sucrose consumption, watermaze with a minimum of
two weeks rest before commencing a new test.
Behavioral Experiments
Since physical deficits are present, we looked at specific
measures during the behavioral tasks to minimize the influence
of these impairments.
Open Field activity, the first behavioral test performed, was
assessed to examine generalized activity and thigmotaxis (wall-
hugging). Animals were placed in an open 30.5 cm by 30.5 cm
space and allowed to explore for ten minutes under dim light
conditions. Horizontal locomotor acivity was measured as beam
breaks by paired sets of photo beams using the Activity Monitor
systems (Med Associates, St. Albans, Vt). We measured thigmo-
taxis (amount of time in the outer versus inner zone), and general
activity levels (velocity and total distance travelled). For the Six5
mutant strain, 6 wild-type and 7 mutant mice were tested. For the
Dmpk mutant strain, 9 wild-type and 9 mutant mice were tested.
For the Mbnl1 mutant strain, 23 wild-type and 19 mutant mice
were tested.
In the elevated plus maze, a second anxiety test, mice were
placed in the center of a four-arm maze and their movement on
the maze was recorded for five minutes in dim light. The maze was
60 cm off the floor. Two arms were sheltered with 16.5 cm
opaque walls and the other two arms were open. We measured the
amount of time in the closed and open arms and the center of the
maze, as well as the number of entries into each arm. The time in
a stretch approach position and the number of times the mice
dipped their heads over the edge of the maze was also scored. We
tested 14 wild-type and 14 Mbnl12/2 mice.
Mice were trained in context fear conditioning. Animals were
placed in the training chamber during which time baseline activity
and freezing levels were obtained, followed by a single shock,
delivered at 4 minutes. After seven days, mice were returned to the
training chamber and tested for long-term memory of the context
by measuring activity and freezing levels. Context fear condition-
ing was performed as previously described [31] using Med
Associated Mouse Context Conditioning boxes. Automated
freezing, activity scores and activity suppression ratios [(test
activity)/(test activity + baseline activity)] were calculated as
previously described [26]. Six wild-type and 6 Six52/2 mice, 10
wild-type and 6 Dmpk2/2 mice, and 12 wild-type and 5
Mbnl12/2 mice were tested in this task.
Morris Water Maze training was commenced to examine spatial
learning and memory of the mutant mice, as previously described
[34]. Briefly, animals are trained to locate a hidden submerged
platform in a pool filled with opaque water. Probe trials, used to
assess spatial memory by examining the search pattern of the mice
when the platform was removed, were administered on days 5, 7, 9
for Dmpk2/2, days 4 and 7 for Six52/2 and days 4, 7, 10 and 13
for Mbnl12/2 mice. Results for the last probe trial are shown.
Pathlengths to find the hidden platform during acquisition were
used in addition to latency as latencies can be influenced by slow
swim speeds. Upon completion of the hidden Water Maze task, all
mice were tested in the visible water maze using a single session
with three training trials in which the location of the submerged
platform is marked by a local cue. This test further controls for
performance, including visual capabilities and muscle deficits.
Mbnl12/2 mice were analysed in two groups, data shown excludes
individual mice that showed .10% thigmotaxis at the end of
training as these mice may have visual complications that affect
distant vision. Analysis of all Mbnl12/2mice is shown in the
supplemental data. For the Dmpk mutant strain, we tested 10 wild-
type and 6 mutant mice, which were trained with two trials per
day. For the Six5 mutant strain, we tested 13 wild-type and 12
mutant mice with two trials per day with probe trials on days 4 and
7. For the Mbnl1 mutant strain, we tested 25 wild type and 21
mutant mice with two trials per day with probe trials. Analysis of
Mbnl12/2 mice was performed both excluding and including mice
that exhibited more than 10% thigmotaxis at the end of training.
This resulted in exclusion of 1 wild type and 8 Mbnl12/2 mice.
Mice were tested for motivation/anhedonia using the sucrose
consumption test. Animals were water restricted overnight on each
day of habituation and testing. Mice were habituated to testing
cages with two drinking spouts, both of which contained water
after which, one solution was replaced with sucrose. Mice were
given 2%, 4%, 8% and 16% sucrose for three days each, the first
day was used as habituation to the new solution. The volume of
either water or sucrose was averaged for the remaining two days,
in which the presentation of water and sucrose was counterbal-
anced. Fourteen wild-type and 14 Mbnl12/2 mice were tested.
Data Analysis
The following software was used for analysis of raw data: Open
Activity from Med Associates for the Open Field, custom designed
software for fear conditioning described [26] and HVS Image for
the water maze. All other behavioral data was obtained by hand-
scoring. ANOVA was used to compare genotypes in the Open
Field (thigmotaxis, velocity and ambulation), Water Maze
(thigmotaxis and velocity), and Fear Conditioning (% freezing
and suppression ratio for baseline and 7 day test, and activity).
Repeated Measures ANOVA was used to compare genotypes in
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the Water Maze (acquisition latency or pathlength, % floating,
visible Water Maze latency, and % time in target quadrant), and
Fear Conditioning (activity bursts). All error bars represent
standard error of the mean.
Supporting Information
Figure S1 Mbnl12/2 mutant mice have altered performance
in the Morris Water Maze. All mice, including Mbnl12/2 mice
that demonstrate pronounced thigmotaxis are included. A) No
statistical differences were found in the latency (seconds) to find the
platform during training (panel i) (effect of genotype x latency
using 2-day blocks, repeated measures ANOVA, F(6,264) = 1.29,
p = 0.26) for Mbnl12/2 mice (white, n = 21) compared to their
Mbnl1+/+ wild-type littermate controls (black, n = 25). A inset:
The pathlength (m) to reach the target platform of Mbnl12/2
(white) was significantly different during acquisition compared to
Mbnl1+/+ mice (black) (effect of genotype x latency
F(6,264) = 2.81, p = 0.012; main effect of genotype
F(1.44) = 7.43, p = 0.0092). Mbnl12/2 mutant mice (white) had
a slower average velocity during all training days (cm/s, panel ii)
(F(1,43) = 52.7, p =,0.0001) and increased thigmotaxis (% time,
panel iii) (F(1,43) = 12.2, p = 0.0011) compared to their wild-type
littermate controls, Mbnl+/+ mice (black). B) The % time spent
swimming slowly (floating behavior) of Mbnl12/2 (white)
increased compared to Mbnl1+/+ mice (black) during acquisition
(F(1,44) = 16.4, p = 0.0002; effect of genotype x latency
F(6,264) = 5.25, p=,0.0001) (panel i). Mbnl12/2 mice showed
increased floating behavior in all training blocks except block 3. C)
Mbnl12/2 mice displayed normal acquisition in the visible water
maze task (pathlength (m), (effect of genotype x pathlength using 2-
day blocks, repeated measures ANOVA, F(2,86) = 0.694,
p = 0.50)). Training blocks represent two days (4 training trials)
for Mbnl1 mutant mice. D) The percent time spent in the Target
Quadrant (TQ), Adjacent Left (AL), Adjacent Right (AR) or
Opposite Quadrant (OP) is shown. A score of 25% reflects random
searching. Probe test results after training are shown. Statistically
significant differences were found in the percent time spent in
searching in each quadrant on day 13 as shown for wild-type
(black) and Mbnl12/2 (white) mice (genotype x quadrant,
repeated measures ANOVA F(3,132) = 5.66, p= 0.0011), main
effect of genotype (F(1,44) = 0.041, p= 0.84). The Mbnl12/2
mice spent significantly less time searching in the target quadrant
(F(1,44) = 7.48, p= 0.0089) and more time in the opposite
quadrant (F= (1,44) = 8.84,p = 0.0048).
Found at: doi:10.1371/journal.pone.0009857.s001 (0.17 MB TIF)
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